查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1944453

全球藥物輸送筆和注射器市場（按產品、治療用途、最終用途、國家和地區分類）－產業分析、市場規模、佔有率和預測（2025-2032年）

Pen And Injector Drug Delivery Devices Market, By Product, By Therapeutic Use, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，藥物輸送筆和注射器設備市場規模將達到 1,138.9756 億美元，從 2025 年到 2032 年的複合年成長率為 9.81%。

醫療專業人員使用輸液筆和注射器作為專用設備，透過皮下或肌肉注射為患者提供精確的藥物劑量，同時確保使用者安全和藥物管理。這些設備由基本組件構成——手動和電子輸液筆以及預裝特定藥物的自動注射器——幫助患者學習如何在家中進行自行注射。這些設備用於治療慢性病和急性疾病，包括糖尿病、肥胖、自體免疫疾病、荷爾蒙缺乏症和過敏性休克，這些疾病都需要患者透過定期注射接受精確的藥物劑量。與傳統的管瓶和注射器注射方式結合使用時，輸液筆和注射器可以減少操作錯誤，並減輕患者的疼痛和焦慮。這提高了患者居家照護治療的依從性，並使其成為現代注射療法（包括生物製劑和特殊藥物）的首選給藥系統。

筆式和注射器式給藥裝置的市場動態

慢性病發生率呈上升趨勢

慢性病發病率的不斷上升是推動注射筆和注射器等給藥裝置市場擴張的主要因素，因為越來越多的患者需要持續、精準的注射藥物治療。糖尿病、肥胖症、自體免疫疾病、心血管疾病和荷爾蒙失衡等患者都需要注射藥物來控制病情，這使得使用者對易於操作的給藥系統的需求持續成長。注射筆和注射器等裝置能夠讓使用者根據精確的劑量資訊自行給藥，與傳統注射器相比，療效更佳。這對於需要終身持續治療的患者尤其重要。對於醫療保健系統和製藥公司而言，注射筆和注射器等裝置是居家醫療的理想解決方案。患者可以在家中接受治療，減少就醫次數，其使用有助於改善患者健康狀況，從而進一步推動市場擴張。

筆式和注射器式給藥裝置市場：細分分析

副產品

截至2024年，注射器式注射劑佔據了最大的市場佔有率。該行業的成長主要得益於類風濕性關節炎、多發性硬化症和糖尿病等慢性疾病患者對易於使用的居家自行注射設備的需求。自動注射器憑藉其人性化的設計和帶有自動給藥系統的隱藏式針頭，提供了一種便捷、安全、可靠的給藥方式，有效避免了注射錯誤並減輕了針刺疼痛。隨著患者越來越傾向於自我給藥，以及生物製藥技術的進步創造了新的機遇，自動注射器的全球使用量正在不斷成長。 2025年10月，肖特製藥（SCHOTT Pharma）透過其syriQ BioPure平台推出了一款5.5毫升大容量預灌封式玻璃注射器，該注射器配備一體式針頭。這款新型注射器可與Ypsomed公司的YpsoMate 5.5大容量自動注射器配合使用，使患者能夠在家中安全便捷地注射生物製藥。以使用者為中心的設計和安全創新將提高可靠性和合規性，使其成為製造商和醫療保健機構關注的關鍵目標。

藥物輸送筆和注射器裝置市場—區域分析

北美地區正經歷顯著的收入成長。現有的醫療保健系統、先進的基礎設施以及創新性的研發活動正在推動該產業的擴張。由於糖尿病和癌症等慢性疾病患者人數眾多，市場持續成長。乳癌。乳癌情況迫切需要開發可靠且易於患者使用的給藥方法。政府法規，以及FDA等機構（負責監管預填充注射筆和自動注射器）的嚴格品質要求，為先進設備的廣泛應用創造了有利條件。 2025年2月，FDA核准了首個速效胰島素生物相似藥Melilog。本產品有兩種規格：3毫升預填充筆和10毫升多劑量管瓶。這項研究表明，監管支持可以幫助更多人獲得注射筆治療。製藥公司與監管機構之間的持續合作將進一步支持北美地區的創新、市場成長和患者療效的改善。

目錄

第1章 注射筆和注射器給藥裝置市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 筆式和注射器式給藥裝置的主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

4. 注射筆和注射器給藥裝置市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

5. 注射筆和注射器給藥裝置市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 筆式和注射器式給藥裝置的市場現狀

  • 筆式和注射器式給藥裝置市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 按產品分類的筆式和注射器式給藥裝置市場

  • 概述
    • 細分市場佔有率分析：依產品分類
    • 噴油嘴型
      • GLP-1促效劑
      • 荷爾蒙療法
      • 生物製藥
      • 其他
    • 筆型
      • GLP-1促效劑
      • 胰島素
      • 荷爾蒙療法
      • 其他

8. 依治療用途分類的筆式和注射器式藥物輸送裝置市場

  • 概述
    • 細分市場佔有率分析：依治療用途分類
    • 自體免疫疾病
    • 糖尿病
    • 腫瘤學
    • 肥胖
    • 內分泌疾病
    • 其他

9. 依最終用途分類的筆式和注射器式藥物輸送裝置市場

  • 概述
    • 細分市場佔有率分析：依最終用途分類
    • 居家醫療環境
    • 醫院
    • 其他

10. 按地區分類的筆式和注射器式藥物輸送裝置市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析－筆式和注射器式給藥裝置產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Amgen, Inc.
    • Merck KGaA
    • Eli Lilly and Company
    • AstraZeneca plc
    • Pfizer, Inc.
    • Sanofi
    • Teva Pharmaceuticals
    • Novo Nordisk A/S
    • Ferring Pharmaceuticals
    • AbbVie Inc.

第12章：分析師視角360度分析

簡介目錄
Product Code: ANV6034

The Pen And Injector Drug Delivery Devices Market size was valued at US$113,897.56 Million in 2024, expanding at a CAGR of 9.81% from 2025 to 2032.

Medical professionals use pen and injector drug delivery devices as special equipment which enables them to deliver exact medication amounts into patients through subcutaneous or intramuscular injections while ensuring user safety and medication control. The devices operate through their basic components, which include both manual and electronic injection pens and autoinjectors that come prefilled with specific medications to help patients learn how to inject themselves at home. People use the devices for both chronic and acute medical conditions which include diabetes, obesity and autoimmune disorders and hormonal deficiencies and anaphylaxis because these conditions require patients to receive precise medication doses through scheduled injections. The use of pen and injector drug delivery devices together with traditional vial-and-syringe methods achieves better dosing accuracy because it decreases handling mistakes while providing patients with less painful and anxious injections, thus enhancing patient treatment compliance through home care, which leads to their selection as the primary drug delivery system for modern injectable treatments, including biologics and specialty pharmaceuticals.

Pen And Injector Drug Delivery Devices Market- Market Dynamics

Rising prevalence of chronic diseases

The increasing occurrence of chronic diseases serves as the primary reason for market expansion of pen and injector drug delivery devices because more patients require continuous and precise delivery of injectable medical treatments. Patients with diabetes and obesity and autoimmune disorders and cardiovascular diseases and hormonal imbalances require injectable drugs to manage their conditions, which creates a constant need for delivery systems that users can operate easily. Pen and injector devices enable users to administer their medication independently while they receive precise dosage information which leads to better treatment results than patients would achieve through traditional syringe usage, especially when this method becomes essential for patients who need continuous therapy throughout their lives. Pen and injector devices function as the preferred solution for home healthcare in medical systems and pharmaceutical companies because they enable patients to receive treatment at home while decreasing the need for hospital visits and their usage leads to better health results for patients which drives market expansion.

Pen And Injector Drug Delivery Devices Market- Segmentation Analysis:

By Product

In 2024, the injectors segment holds the largest market share. The growth of this industry occurs because patients with chronic diseases such as rheumatoid arthritis, multiple sclerosis, and diabetes demand user-friendly self-injection equipment which allows them to conduct home treatment. Autoinjectors deliver a simple yet secure and dependable delivery method because they include hidden needles with automatic dosage systems and user-friendly designs which help users to avoid mistakes and experience less needle pain. The worldwide use of autoinjectors increases because patients now prefer to administer their medications themselves, while advances in biologics create new opportunities. SCHOTT Pharma introduced a 5.5 ml large-volume prefillable staked-needle glass syringe through its syriQ BioPure platform in October 2025. This new syringe works with Ypsomed's YpsoMate 5.5 large-volume autoinjector, which allows users to safely and easily inject biologic treatments at their homes. User-centric design and safety innovations build confidence and compliance, which makes this area a major target for producers and medical organizations to concentrate their efforts.

Pen And Injector Drug Delivery Devices Market- Geographical Insights

North America region experiences strong revenue growth. The existing healthcare system together with advanced infrastructure and research and development activities with innovative outcomes creates the engine that drives industry expansion. The market experiences growth because many people suffer from chronic diseases which include diabetes and cancer. Breast cancer is one of the most diagnosed cancers among women in the U.S. According to the American Cancer Society, Inc., in 2024, breast cancer was diagnosed in over 310,000 women in the country. The situation requires development of trustworthy delivery methods that patients can easily use. Advanced device usage increases due to government regulations that create favorable conditions together with strict quality requirements from organizations like the FDA which govern prefilled pens and autoinjectors. The FDA approved the first rapid-acting insulin biosimilar Merilog in February 2025 which comes in two formats a 3 ml prefilled pen and a 10 ml multi-dose vial. The study demonstrates that regulatory assistance enables more people to access pen-based injectable therapies. Ongoing collaboration between pharmaceutical companies and regulatory authorities further supports innovation, market growth, and enhanced patient outcomes across North America.

Pen And Injector Drug Delivery Devices Market- Competitive Landscape:

The pen and injector drug-delivery market exists as a competitive sphere which combines two opposing forces. The market consists of pharmaceutical companies that control their entire production process and create their own pen systems together with their exclusive drug portfolio. The market includes specialized device manufacturers and contract manufacturers who create precise engineering solutions and supply special components and custom products. The market predominantly belongs to major pharmaceutical companies which include Novo Nordisk, Eli Lilly, and Sanofi, because they combine their high-demand biologics products with proprietary pen systems. The pharmaceutical industry depends on Becton Dickinson, Ypsomed, SHL Medical, West Pharmaceutical Services, and Gerresheimer for their reusable and disposable platforms, fill-finish interfaces, and outsourced manufacturing capabilities. The market competition develops through strategic partnerships and licensing agreements and mergers and acquisitions because drugmakers require unique user-friendly pen systems that include connected and electronic pens. Device companies expand their product offerings to develop solutions that will help them secure long-term customer contracts. The market faces pricing challenges because of demand uncertainty in developing regions. The market faces heightened competition because of increasing demand for smart pens which provide data collection and adherence services as well as the expansion of GLP-1 pen products throughout different regions. The competition created opportunities for mid-sized contract manufacturers to acquire business from their larger competitors who dominate the market.

Recent Developments:

In October 2025, Stevanato Group S.p.A. announced a major expansion of its drug delivery system manufacturing capacity in Germany. This move strengthens its presence in Europe. The company added over 2,500 square meters of new production space to its Bad Oeynhausen facility. This includes an ISO 8 cleanroom for injection molding and automated assembly. The multi-million-euro investment improves scalability, supply chain resilience, and support for both proprietary and contract manufacturing of drug delivery devices, including autoinjector and pen injector platforms.

In September 2025, Apiject Systems Corp. announced that it had submitted a New Drug Application to the U.S. FDA for the first injectable medicine delivered with its single-dose, single-use prefilled plastic syringe. This submission included glycopyrrolate, which is given through Apiject's special injection device. This device combined Blow-Fill-Seal liquid packaging with precisely molded needle hubs. This platform allowed for scalable and cost-effective manufacturing using materials sourced in the U.S., providing an alternative to standard glass vials and prefilled syringes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen, Inc.
  • Merck KGaA
  • Eli Lilly and Company
  • AstraZeneca plc
  • Pfizer, Inc.
  • Sanofi
  • Teva Pharmaceuticals
  • Novo Nordisk A/S
  • Ferring Pharmaceuticals
  • AbbVie Inc.

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Injectors
  • GLP-1 Agonists
  • Hormone Therapies
  • Biologics
  • Others
  • Pen
  • GLP-1 Agonists
  • Insulin
  • Hormone Therapies
  • Others

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC USE - MARKET ANALYSIS, 2019 - 2032

  • Autoimmune Disorders
  • Diabetes Mellitus
  • Oncology
  • Obesity
  • Hormonal Disorders
  • Others

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Homecare Settings
  • Hospitals
  • Others

GLOBAL Pen And Injector Drug Delivery Devices MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pen And Injector Drug Delivery Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pen And Injector Drug Delivery Devices Market Snippet by Product
    • 2.1.2. Pen And Injector Drug Delivery Devices Market Snippet by Therapeutic Use
    • 2.1.3. Pen And Injector Drug Delivery Devices Market Snippet by End Use
    • 2.1.4. Pen And Injector Drug Delivery Devices Market Snippet by Country
    • 2.1.5. Pen And Injector Drug Delivery Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Pen And Injector Drug Delivery Devices Key Market Trends

  • 3.1. Pen And Injector Drug Delivery Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pen And Injector Drug Delivery Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pen And Injector Drug Delivery Devices Market Opportunities
  • 3.4. Pen And Injector Drug Delivery Devices Market Future Trends

4. Pen And Injector Drug Delivery Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pen And Injector Drug Delivery Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pen And Injector Drug Delivery Devices Market Landscape

  • 6.1. Pen And Injector Drug Delivery Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pen And Injector Drug Delivery Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024&2032 (%)
    • 7.1.2. Injectors
      • 7.1.2.1. GLP-1 Agonists
      • 7.1.2.2. Hormone Therapies
      • 7.1.2.3. Biologics
      • 7.1.2.4. Others
    • 7.1.3. Pen
      • 7.1.3.1. GLP-1 Agonists
      • 7.1.3.2. Insulin
      • 7.1.3.3. Hormone Therapies
      • 7.1.3.4. Others

8. Pen And Injector Drug Delivery Devices Market - By Therapeutic Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Use, 2024&2032 (%)
    • 8.1.2. Autoimmune Disorders
    • 8.1.3. Diabetes Mellitus
    • 8.1.4. Oncology
    • 8.1.5. Obesity
    • 8.1.6. Hormonal Disorders
    • 8.1.7. Others

9. Pen And Injector Drug Delivery Devices Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024&2032 (%)
    • 9.1.2. Homecare Settings
    • 9.1.3. Hospitals
    • 9.1.4. Others

10. Pen And Injector Drug Delivery Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pen And Injector Drug Delivery Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Pen And Injector Drug Delivery Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Amgen, Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. AstraZeneca plc
    • 11.2.5. Pfizer, Inc.
    • 11.2.6. Sanofi
    • 11.2.7. Teva Pharmaceuticals
    • 11.2.8. Novo Nordisk A/S
    • 11.2.9. Ferring Pharmaceuticals
    • 11.2.10. AbbVie Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us